JPAD-Journal of Prevention of Alzheimers Disease
Scope & Guideline
Pioneering Research to Safeguard Cognitive Health
Introduction
Aims and Scopes
- Prevention Strategies and Interventions:
The journal emphasizes the development and evaluation of various prevention strategies aimed at delaying or preventing cognitive decline and Alzheimer's disease. This includes lifestyle modifications, dietary interventions, and community-based programs. - Biomarkers and Diagnostic Tools:
Research on biomarkers for early detection and diagnosis of Alzheimer's disease is a core focus. This includes studies on blood, imaging, and genetic biomarkers that can help identify individuals at risk and monitor disease progression. - Cognitive Function Assessment:
JPAD publishes studies that explore cognitive assessments and their relevance in clinical and community settings. This includes the validation of new cognitive tests and the use of digital tools to evaluate cognitive function. - Health Equity and Access:
The journal addresses disparities in Alzheimer's disease research and treatment, focusing on recruitment strategies for underrepresented populations in clinical trials and the role of social determinants of health. - Innovative Therapeutic Approaches:
Research into new therapeutic strategies, including pharmacological and non-pharmacological interventions, is a significant area of interest. This includes studies on the efficacy of new drugs, dietary supplements, and lifestyle changes. - Longitudinal Studies and Cohort Analyses:
JPAD often features longitudinal studies that track cognitive decline over time, providing insights into the progression of Alzheimer's disease and associated risk factors.
Trending and Emerging
- Digital Health Interventions:
The use of digital technologies for cognitive assessments, monitoring, and interventions is rapidly gaining traction. Research exploring how mobile applications and online platforms can enhance cognitive health is increasingly prevalent. - Personalized Medicine Approaches:
There is a growing emphasis on personalized medicine in Alzheimer's research, with studies focusing on tailoring interventions based on individual genetic, lifestyle, and health profiles. - Multidomain Lifestyle Interventions:
Research on multidomain interventions that combine dietary, physical, and cognitive activities to prevent cognitive decline is on the rise, reflecting an integrated approach to Alzheimer's prevention. - Community Engagement in Research:
The journal is increasingly highlighting the importance of community engagement in Alzheimer's research, particularly in recruiting diverse populations for clinical trials and addressing health disparities. - Neuroinflammation and Immune Response:
Emerging research into the role of neuroinflammation and the immune response in Alzheimer's disease is gaining prominence, with studies investigating therapeutic strategies targeting these pathways. - Social Determinants of Health:
There is an increasing focus on how social determinants, such as socioeconomic status and access to care, impact cognitive health and the progression of Alzheimer's disease.
Declining or Waning
- Historical Epidemiological Studies:
There has been a noticeable decrease in the publication of traditional epidemiological studies that solely focus on historical data without integrating contemporary methods or innovative approaches. - Single-Factor Risk Assessments:
Research solely emphasizing single-factor risk assessments for Alzheimer's disease is declining. The trend is moving towards multifactorial approaches that consider a combination of genetic, environmental, and lifestyle factors. - Basic Science Research:
Studies focused exclusively on basic biological mechanisms of Alzheimer's disease without practical implications for prevention or intervention are becoming less frequent, as the journal emphasizes translational research. - Pharmacological Monotherapy Trials:
There is a waning interest in studies that evaluate the effectiveness of pharmacological monotherapies for Alzheimer's treatment, as the focus shifts towards combination therapies and holistic approaches.
Similar Journals
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
Exploring the complexities of geriatric psychiatry and neurology.JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.
Journal of Nutrition Health & Aging
Championing impactful research for vibrant aging.Welcome to the Journal of Nutrition Health & Aging, a prestigious publication dedicated to advancing knowledge in the critical fields of nutrition, gerontology, and geriatrics. Published by Elsevier Science Inc, this journal boasts an impressive impact factor and is recognized in the top quartile (Q1) of multiple categories including Geriatrics and Gerontology, Medicine (miscellaneous), and Nutrition and Dietetics. Since its inception in 1997, it has served as a vital platform for researchers, practitioners, and students alike to disseminate innovative research and practical applications relevant to aging populations. With a Scopus rank placing it in the top 15% of its field, it underscores its commitment to high-quality and impactful scholarship. Although it is not an open access journal, its significant reach ensures that valuable insights will continue to inform best practices and policy decisions in health and nutrition. We invite you to explore and contribute to this vital conversation surrounding health and well-being in older adults.
American Journal of Alzheimers Disease and Other Dementias
Exploring the frontiers of dementia research.The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.
Psychogeriatrics
Advancing mental health insights for the aging population.Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.
JOURNAL OF ALZHEIMERS DISEASE
Uniting disciplines to combat Alzheimer's disease.Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.
Frontiers in Aging Neuroscience
Advancing Knowledge for a Healthier Brain in Old Age.Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.
BRAIN
Pioneering Research at the Intersection of Neurology and MedicineBRAIN, published by Oxford University Press, stands as a preeminent journal in the realms of neurology and medicine, with a formidable impact factor reflecting its rigorous peer-reviewed standards and significant contributions to the field. With its ISSN 0006-8950 and E-ISSN 1460-2156, this esteemed publication spans over a century of exceptional research, converging from its historical roots in 1878 to current groundbreaking studies. BRAIN boasts a distinguished rank of #8 out of 400 in the Scopus category of Neurology (Clinical), placing it in the 98th percentile of institutions, indicative of its influence and reach. Operating under the Q1 category in both Medicine (Miscellaneous) and Clinical Neurology, the journal is dedicated to fostering interdisciplinary dialogue among researchers, clinicians, and students alike. With a focus on innovative findings and clinical advancements, BRAIN serves as a vital resource for those seeking to deepen their understanding of neurological disorders and the evolving landscape of medical research.
Early Intervention in Psychiatry
Elevating Mental Health: The Journal of Timely InterventionsEarly Intervention in Psychiatry, published by WILEY, is an esteemed academic journal dedicated to advancing the field of psychiatry and mental health through rigorous research and innovative practices. Established in 2007 and continuing through 2024, this journal serves as a critical resource for researchers, clinicians, and students interested in the early detection and treatment of psychiatric disorders. With an ISSN of 1751-7885 and an E-ISSN of 1751-7893, it is recognized for its significant contributions, placing in the Q3 quartile in Biological Psychiatry and Q2 in Psychiatry and Mental Health as of 2023. The journal boasts impressive Scopus rankings, being placed 12th in Nursing - Psychiatric Mental Health and 27th in Neuroscience - Biological Psychiatry, showcasing its impact within the scientific community. While not an open-access journal, its findings are pivotal for those seeking to enhance mental health interventions. Early Intervention in Psychiatry is committed to fostering knowledge and improving practices that ultimately contribute to better mental health outcomes globally.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Advancing understanding in Alzheimer’s and cognitive health.ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.
Cancer Prevention Research
Bridging laboratory discoveries with community health.Cancer Prevention Research, published by the American Association for Cancer Research, is a leading journal dedicated to advancing our understanding of cancer prevention strategies and their implementation in public health. With an ISSN of 1940-6207 and E-ISSN 1940-6215, this journal serves as a pivotal platform for researchers, healthcare professionals, and students who are committed to unraveling the complexities of cancer etiology and preventive measures. Since its inception in 2008, the journal has carved a niche in the scientific community, achieving notable rankings including Q2 in Cancer Research and Q1 in both Medicine (miscellaneous) and Oncology, highlighting its significance in disseminating influential research. Cancer Prevention Research is indexed in Scopus, reflecting a robust impact factor, and features a range of articles that address the preventive aspects of cancer to promote healthier populations. With access options available, it invites contributions that bridge laboratory findings with epidemiologic insights, making it an essential resource for anyone dedicated to reducing the burden of cancer globally.